Nutritional Outcomes of Lotus Seed (Nelumbo Nucifera) on Diabetic Sensorimotor Polyneuropathy

Launched by RIPHAH INTERNATIONAL UNIVERSITY · Jan 10, 2025

Keywords

ClinConnect Summary

This clinical trial is studying the effects of Lotus Seed on patients with Type 2 Diabetes Mellitus who also experience a condition called Diabetic Sensorimotor Polyneuropathy (DSPN). DSPN is a complication of diabetes that can cause pain, numbness, and weakness in the limbs, and it can affect other parts of the body as well. Researchers want to see if Lotus Seed can help improve nerve function and overall health in these patients. Participants will be divided into two groups: one will receive a standard diabetes treatment with placebo capsules, and the other will receive the same treatment along with Lotus Seed capsules for 12 months.

To be eligible for the trial, participants must be at least 40 years old, have been diagnosed with Type 2 Diabetes and experience neuropathy symptoms for at least a year. Both men and women can join, as long as they understand basic instructions. However, individuals with certain health conditions, such as heart disease or cancer, cannot participate. Throughout the trial, researchers will monitor health changes through tests that check weight, blood sugar levels, and nerve function. This study aims to find out if Lotus Seed can be a beneficial addition to diabetes care.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Participants who have been clinically diagnosed with T2DM (Type 2 Diabetes Mellitus).
• • Participants who have been clinically diagnosed with neuropathy symptoms for at least 1 year.
• • Both male and female participants.
• • Participants aged 40 years and older.
• • Participants capable of understanding basic instructions, either independently or with assistance from their family.
• Exclusion Criteria:
• • Individuals with a clinical diagnosis of cardiovascular conditions.
• • Cancer patients will be excluded from the study.
• • Individuals diagnosed with rheumatoid arthritis.
• • Individuals with a urinary tract infection.
• • Individuals diagnosed with psychological disorders.
• • Pregnant or breastfeeding women.